These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31423214)

  • 1. Low expression of miR-125a-5p is associated with poor prognosis in patients with gastric cancer.
    Li G; Ao S; Hou J; Lyu G
    Oncol Lett; 2019 Aug; 18(2):1483-1490. PubMed ID: 31423214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-125a-5p inhibits invasion and metastasis of gastric cancer cells by targeting BRMS1 expression.
    Cao Y; Tan S; Tu Y; Zhang G; Liu Y; Li D; Xu S; Le Z; Xiong J; Zou W; Gong P; Li Z; Jie Z
    Oncol Lett; 2018 Apr; 15(4):5119-5130. PubMed ID: 29552146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.
    Nishida N; Mimori K; Fabbri M; Yokobori T; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Mori M
    Clin Cancer Res; 2011 May; 17(9):2725-33. PubMed ID: 21220473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silenced miR-125a-5p could be self-activated through targeting Suv39H1 in gastric cancer.
    Cai M; Chen Q; Shen J; Lv C; Cai L
    J Cell Mol Med; 2018 Oct; 22(10):4721-4731. PubMed ID: 30117667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
    Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
    Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.
    Hashiguchi Y; Nishida N; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Mochizuki H; Hase K; Doki Y; Mori M
    Int J Oncol; 2012 May; 40(5):1477-82. PubMed ID: 22322911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of hsa-miR-125a-5p enhances proliferation, migration and invasion of head and neck squamous cell carcinoma cell lines by upregulating C-C chemokine receptor type 7.
    Jin S; Liu MD; Wu H; Pang P; Wang S; Li ZN; Sun CF; Liu FY
    Oncol Lett; 2018 Jun; 15(6):9703-9710. PubMed ID: 29928346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced miR-125a-5p expression is associated with gastric carcinogenesis through the targeting of E2F3.
    Xu Y; Huang Z; Liu Y
    Mol Med Rep; 2014 Nov; 10(5):2601-8. PubMed ID: 25231560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA.
    Yang X; Qiu J; Kang H; Wang Y; Qian J
    Cancer Manag Res; 2018; 10():5839-5853. PubMed ID: 30510452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
    Qin X; Wan Y; Wang S; Xue M
    Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced miR-125a levels associated with poor survival of patients with hepatocellular cancer.
    Lu G; Ma Y; Jia C; Yang H; Xie R; Luo P; Chai L; Cai H; Cai M; Lv Z; Cong X; Fu D
    Oncol Lett; 2017 Nov; 14(5):5952-5958. PubMed ID: 29113231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer.
    Zhang HD; Jiang LH; Hou JC; Zhong SL; Zhou SY; Zhu LP; Li J; Wang DD; Sun DW; Ji ZL; Tang JH
    Biomed Pharmacother; 2018 Nov; 107():1342-1353. PubMed ID: 30257349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC.
    Xu J; Wang Y; Zhang Y; Dang S; He S
    Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma.
    Fu Y; Cao F
    Onco Targets Ther; 2015; 8():3827-35. PubMed ID: 26719710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-125a-5p expression is associated with the age of breast cancer patients.
    He H; Xu F; Huang W; Luo SY; Lin YT; Zhang GH; Du Q; Duan RH
    Genet Mol Res; 2015 Dec; 14(4):17927-33. PubMed ID: 26782438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of miR-125a-5p on Cell Proliferation,Apoptosis and Cell Cycle of Pancreatic Cancer Cells.
    Jia CW; Sun Y; Zhang TT; Lu ZH; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Aug; 38(4):415-21. PubMed ID: 27594154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-125a-5p decreases after long non-coding RNA HOTAIR knockdown to promote cancer cell apoptosis by releasing caspase 2.
    Tang L; Shen H; Li X; Li Z; Liu Z; Xu J; Ma S; Zhao X; Bai X; Li M; Wang Q; Ji J
    Cell Death Dis; 2016 Mar; 7(3):e2137. PubMed ID: 26962687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Aberrant Expression of MicroRNA-125a-5p/IGF2BP3 Axis in Advanced Gastric Cancer and Its Clinical Relevance.
    Zhang J; Ding F; Jiao D; Li Q; Ma H
    Technol Cancer Res Treat; 2020; 19():1533033820917332. PubMed ID: 32266868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MARK1 is a Novel Target for miR-125a-5p: Implications for Cell Migration in Cervical Tumor Cells.
    Natalia MA; Alejandro GT; Virginia TJ; Alvarez-Salas LM
    Microrna; 2018; 7(1):54-61. PubMed ID: 29076440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.